Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.34 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | ERBB2 | P04626 | 1/20 | 0.33 |
| ▸ | FYN | P06241 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | AHR | P35869 | 1/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.32 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | PPARG | P37231 | 5/20 | 0.31 |
| ▸ | PPARA | Q07869 | 5/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PPARD | Q03181 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL557128 | 1.00 | SIGMAR1 (0.34) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL556604 | 0.98 | SIGMAR1 (0.34) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL556520 | 0.96 | SIGMAR1 (0.35) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL10029014 | 0.95 | ERBB2 (0.34) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL10028985 | 0.94 | SIGMAR1 (0.38) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL10029019 | 0.93 | ERBB2 (0.34) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL10028998 | 0.93 | SIGMAR1 (0.37) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL10029015 | 0.92 | CYP1A2 (0.35) | SIGMAR1CYP1A2ERBB2FYNMAOA | |
| SCHEMBL10028986 | 0.92 | GSTP1 (0.31) | CYP1A2ERBB2FYNMAOAACHE | |
| SCHEMBL556217 | 0.92 | GSTP1 (0.31) | CYP1A2ERBB2FYNMAOAACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8586211-B2 | Asymmetrical aryl amine derivative for organic electroluminescence devices, method for preparing same, organic thin film for organic electroluminescence devices and organic electroluminescence device using same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2013-11-19 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | DONGWOO FINE-CHEM CO. LTD. (KR) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120032152-A1 | Asymmetrical Aryl Amine Derivative for Organic Electroluminescence Devices, Method for Preparing Same, Organic Thin Film for Organic Electroluminescence Devices and Organic Electroluminescence Device Using Same | AOC2, ALKBH2, ALKBH1 | SIGMAR1 1436/4885CYP1A2 143/4885ERBB2 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.